| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | UWU93Y99R3 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Complement factor D inhibitor |
| Primary Target | |
|---|---|
| complement factor D |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Geographic Atrophy | 3 | D057092 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1278466-20-8 |
| ChEMBL | CHEMBL2109408 |
| FDA SRS | UWU93Y99R3 |
| Guide to Pharmacology | 8294 |
CONTENTS